- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/38 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 333/38
Total number of patents in this class: 714
10-year publication summary
50
|
33
|
40
|
40
|
41
|
33
|
42
|
49
|
33
|
22
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Allergan, Inc. | 2345 |
32 |
Takeda Pharmaceutical Company Limited | 2696 |
28 |
Bayer AG | 3336 |
23 |
BASF SE | 20915 |
10 |
Astellas Pharma Inc. | 1091 |
10 |
Nissan Chemical Industries, Ltd. | 1716 |
8 |
AstraZeneca AB | 2900 |
7 |
EA Pharma Co., Ltd. | 88 |
7 |
Boehringer Ingelheim International GmbH | 4644 |
6 |
Bayer Cropscience AG | 2035 |
6 |
Bayer Cropscience SA | 36 |
6 |
Bayer Pharma AG | 1047 |
6 |
Vertex Pharmaceuticals Incorporated | 1595 |
6 |
Alcon, Inc. | 5440 |
6 |
Global Blood Therapeutics, Inc. | 183 |
6 |
Kissei Pharmaceutical Co., Ltd. | 184 |
6 |
Corteva Agriscience LLC | 2664 |
6 |
Xwpharma Ltd. | 57 |
6 |
Activesite Pharmaceuticals, Inc. | 19 |
5 |
ADAMA Agan Ltd. | 377 |
5 |
Other owners | 519 |